查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463021

临床试验影像市场,占有率,规模,趋势,产业分析报告:依产品,模式,应用,最终用户,地区,细分市场进行预测2024-2032 年

Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球临床试验影像市场规模预计将达到2,2501.2亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

临床试验成像市场是由全球慢性病的流行所推动的。心血管疾病、癌症和神经系统疾病等疾病呈现上升趋势，开发治疗方法的努力也不断增加。临床试验影像利用 MRI、CT、PET 和超音波等方式，在评估疾病进展、治疗反应和患者结果方面发挥着至关重要的作用。随着进行更大规模、更复杂的临床试验来评估新疗法，影像终点提供了治疗效果的客观指标。监管机构要求药物审批提供可靠的影像数据，进一步推动对临床试验影像服务的需求。

临床试验成像市场也受到成像生物标记应用不断扩大的推动。这些生物标记提供生物过程和治疗反应的定量测量，可用于各个治疗领域的疾病监测和治疗评估。它们在精准医疗和个人化治疗中发挥关键作用，能够实现有针对性的干预并改善治疗结果。成像技术和分析方法的进步扩大了可用于临床的成像生物标记的范围。此外，人工智慧 (AI) 和机器学习演算法的整合正在增强生物标记分析、简化数据处理并提高临床试验的可重复性。

人工智慧（AI）技术的整合为临床试验成像市场带来了重大机会。机器学习和深度学习模型等人工智慧演算法透过自动化任务、减少错误和加快数据处理速度，正在彻底改变医学影像分析。在临床试验中，人工智慧驱动的影像分析透过快速识别影像生物标记的细微变化来提高效率，促进早期治疗反应检测。此外，基于人工智慧的解决方案可以从大型影像资料集中获得有价值的见解，以帮助患者分层和治疗选择。其可扩展性和适应性简化了临床试验操作并促进利害关係人之间的协作。

结合不同的成像模式（例如 MRI、PET、CT 和光学成像）可为研究人员提供补充讯息，从而提高诊断准确性和治疗评估。多模态成像克服了单一模态的局限性，提供了对疾病病理学和治疗效果的全面瞭解。结合多个成像参数也将促进新型成像生物标记的开发，从而更深入地瞭解疾病进展和治疗效果。此外，影像配准、融合技术和人工智慧演算法的进步将简化数据分析并促进临床试验设计和实施的创新。

临床试验成像市场报告亮点

2023年，由于其在整个临床试验过程中的不可或缺的作用、灵活性和可扩展性以及成本效益，操作成像服务行业占据了重要的收入占有率。

2023年，电脑断层扫瞄领域因其诊断多功能性、应用范围广泛和影像撷取快速而占据了很大的收入占有率。

2023年，由于肿瘤临床试验的高发生率、肿瘤临床试验的复杂性以及肿瘤药物管线的不断增加，肿瘤领域占据了重要的收入占有率。

由于药物开发措施、精准医学的进步和治疗创新，製药和生技公司的需求预计在预测期内将会增加。

2023年，北美地区由于先进的医疗基础设施、大量的临床试验以及大型製药公司的存在，占据了主要的市场占有率。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球临床试验影像市场洞察

  • 临床试验成像 - 产业快照
  • 临床试验成像市场动态
    • 驱动因素和机遇
      • 临床试验活动的增加预计将推动对该产品的需求。
      • 成像技术的进步预计将推动临床试验成像市场的成长
    • 限制因素和课题
      • 诊断影像服务的高成本可能会阻碍市场成长
  • PESTLE分析
  • 临床试验成像产业的趋势
  • 价值链分析
  • COVID-19 影响分析

第 5 章 全球市场（依产品划分）

  • 主要发现
  • 介绍
  • 临床试验设计与咨询服务
  • 营运影像服务
  • 专案和资料管理
  • 阅读与分析服务
  • 系统和技术支援服务
  • 其他

第六章依形态划分的全球市场

  • 主要发现
  • 介绍
  • 超声波
  • CT检查
  • X光
  • 磁共振成像
  • 其他

第七章依应用划分的世界市场

  • 主要发现
  • 介绍
  • 神经病学
  • 肿瘤学
  • 感染
  • 内分泌学
  • 眼科
  • 心血管疾病
  • 其他

第八章最终用户的全球市场

  • 主要发现
  • 介绍
  • 製药和生物技术公司
  • 合约调查机构
  • 医疗器械製造商
  • 学术和政府研究机构
  • 其他

第 9 章依地区划分的世界市场

  • 主要发现
  • 介绍
    • 临床试验影像市场评估（依地区），2019-2032
  • 临床试验影像市场 - 北美
    • 北美：2019-2032 年临床试验影像市场（依产品划分）
    • 北美：临床试验成像市场，依最终用户划分，2019-2032 年
    • 北美：临床试验影像市场（依模式），2019-2032 年
    • 北美：临床试验影像市场，依应用分类，2019-2032
    • 临床试验影像市场—美国
    • 临床试验影像市场 - 加拿大
  • 临床试验影像市场 - 欧洲
    • 欧洲：临床试验影像市场（依产品划分），2019-2032 年
    • 欧洲：临床试验影像市场，依最终使用者划分，2019-2032 年
    • 欧洲：临床试验影像市场（依模式），2019-2032 年
    • 欧洲：临床试验影像市场，依应用分类，2019-2032
    • 临床试验影像市场—英国
    • 临床试验影像市场—法国
    • 临床试验影像市场—德国
    • 临床试验影像市场—义大利
    • 临床试验影像市场—西班牙
    • 临床试验影像市场—荷兰
    • 临床试验影像市场—俄罗斯
  • 临床试验影像市场 - 亚太地区
    • 亚太地区：临床试验影像市场（依产品分类），2019-2032 年
    • 亚太地区：临床试验影像市场，依最终使用者划分，2019-2032 年
    • 亚太地区：临床试验影像市场（依模式），2019-2032 年
    • 亚太地区：临床试验影像市场，依应用划分，2019-2032 年
    • 临床试验影像市场 - 中国
    • 临床试验影像市场—印度
    • 临床试验影像市场 - 日本
    • 临床试验影像市场—马来西亚
    • 临床试验影像市场—印度尼西亚
    • 临床试验影像市场—韩国
  • 临床试验影像市场—中东和非洲
    • 中东和非洲：临床试验影像市场（依产品分类），2019-2032 年
    • 中东和非洲：临床试验影像市场，依最终用户划分，2019-2032 年
    • 中东和非洲：临床试验影像市场（依模式），2019-2032 年
    • 中东和非洲：临床试验影像市场，依应用分类，2019-2032
    • 临床试验影像市场—沙乌地阿拉伯
    • 临床试验影像市场—南非
    • 临床试验影像市场—以色列
    • 临床试验影像市场 - 阿联酋
  • 临床试验影像市场—拉丁美洲
    • 拉丁美洲：临床试验影像市场（依产品分类），2019-2032 年
    • 拉丁美洲：临床试验成像市场，依最终用户划分，2019-2032 年
    • 拉丁美洲：临床试验影像市场（依模式），2019-2032 年
    • 拉丁美洲：临床试验影像市场，依应用划分，2019-2032 年
    • 临床试验影像市场—墨西哥
    • 临床试验影像市场 - 巴西
    • 临床试验影像市场—阿根廷

第10章竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/出版物

第十一章公司简介

  • BioClinica
  • Biomedical Systems Corp
  • BioTelemetry, Inc.
  • Cardiovascular Imaging Technologies
  • ICON plc
  • Intrinsic Imaging
  • IXICO plc
  • Median Technologies
  • Medpace
  • Merge Healthcare
  • Navitas Clinical Research, Inc
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health
  • WorldCare Clinical
Product Code: PM4696

The global clinical trial imaging market size is expected to reach USD 2,250.12 Million by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The clinical trial imaging market is propelled by the escalating prevalence of chronic diseases globally. Conditions like cardiovascular diseases, cancer, and neurological disorders are increasing, prompting heightened efforts in therapy development. Clinical trial imaging, utilizing modalities such as MRI, CT, PET, and ultrasound, plays a pivotal role in evaluating disease progression, treatment response, and patient outcomes. With larger and more intricate trials conducted to assess new interventions, imaging endpoints provide objective measures of treatment effects. Regulatory agencies mandate robust imaging data for drug approval, further boosting the demand for clinical trial imaging services.

The clinical trial imaging market is also experiencing growth driven by the expanding applications of imaging biomarkers. These biomarkers offer quantitative measurements of biological processes or treatment responses, aiding in disease monitoring and treatment evaluation across various therapeutic areas. They play a crucial role in precision medicine and personalized therapies, enabling targeted interventions and improving therapeutic outcomes. Advancements in imaging technologies and analytical methods have broadened the range of imaging biomarkers available for clinical use. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced biomarker analysis, streamlining data processing and improving reproducibility in clinical trials.

The integration of artificial intelligence (AI) technologies presents significant opportunities in the clinical trial imaging market. AI algorithms, such as machine learning and deep learning models, revolutionize medical image analysis by automating tasks, reducing errors, and expediting data processing. In clinical trials, AI-driven imaging analysis enhances efficiency by rapidly identifying subtle changes in imaging biomarkers, facilitating early treatment response detection. Moreover, AI-based solutions unlock valuable insights from large-scale imaging datasets, aiding in patient stratification and treatment selection. Their scalability and adaptability streamline trial operations, fostering collaboration among stakeholders.

By combining different imaging modalities like MRI, PET, CT, and optical imaging, researchers obtain complementary information, improving diagnostic accuracy and treatment assessment. Multi-modal imaging offers a comprehensive understanding of disease pathology and treatment effects, overcoming the limitations of individual modalities. It facilitates the development of novel imaging biomarkers by combining multiple imaging parameters, enhancing insights into disease progression and treatment response. Furthermore, advancements in image registration, fusion techniques, and AI algorithms streamline data analysis, driving innovation in clinical trial design and execution.

Clinical Trial Imaging Market Report Highlights

In 2023, the operational imaging services segment held considerable revenue share owing to its essential role in entire clinical trial process, flexibility and scalability, and cost-effectiveness.

In 2023, the computed tomography segment held significant revenue share owing to diagnostic versatility, wide application spectrum, and rapid imaging acquisition.

In 2023, the oncology segment held significant revenue share owing to high incidence of oncology trials, complexity of oncology trials, and growing pipeline of oncology drugs.

The demand from pharmaceutical & biotechnology companies is expected to increase during the forecast period owing to drug development initiatives, precision medicine advancements, and therapeutic innovation.

In 2023, North America region accounted for a significant market share due to advanced healthcare infrastructure, high volume of clinical trials, and presence of leading pharmaceutical companies.

The market is highly competitive owing to the existence of market players with a global presence, including BioClinica, BioTelemetry, Inc., Cardiovascular Imaging Technologies, ICON plc, Merge Healthcare, Navitas Clinical Research, Inc, Resonance Health, and WorldCare Clinical among others.

Polaris Market Research has segmented the Clinical Trial Imaging market report based on offering, modality, application, end user, and region:

Clinical Trial Imaging, Offering Outlook (Revenue - USD Million, 2019 - 2032)

  • Clinical Trial Design and Consultation Services
  • Operational Imaging Services
  • Project and Data Management
  • Reading and Analytical Services
  • System and Technology Support Services
  • Others

Clinical Trial Imaging, Modality Outlook (Revenue - USD Million, 2019 - 2032)

  • Ultrasound
  • Computed Tomography
  • X-Ray
  • Magnetic Resonance Imaging
  • Others

Clinical Trial Imaging, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Neurology
  • Oncology
  • Infectious Diseases
  • Endocrinology
  • Ophthalmology
  • Cardiovascular Diseases
  • Others

Clinical Trial Imaging, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Medical Device Manufacturers
  • Academic and Government Research Institutes
  • Others

Clinical Trial Imaging, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Clinical Trial Imaging Market Insights

  • 4.1. Clinical Trial Imaging - Industry Snapshot
  • 4.2. Clinical Trial Imaging Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing clinical trial activities are projected to spur the product demand
      • 4.2.1.2. Advancement in imaging technologies is expected to drive clinical trial imaging market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of imaging services is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Clinical Trial Imaging Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Clinical Trial Imaging Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • 5.3. Clinical Trial Design and Consultation Services
    • 5.3.1. Global Clinical Trial Imaging Market, by Clinical Trial Design and Consultation Services, by Region, 2019-2032 (USD Million)
  • 5.4. Operational Imaging Services
    • 5.4.1. Global Clinical Trial Imaging Market, by Operational Imaging Services, by Region, 2019-2032 (USD Million)
  • 5.5. Project and Data Management
    • 5.5.1. Global Clinical Trial Imaging Market, by Project and Data Management, by Region, 2019-2032 (USD Million)
  • 5.6. Reading and Analytical Services
    • 5.6.1. Global Clinical Trial Imaging Market, by Reading and Analytical Services, by Region, 2019-2032 (USD Million)
  • 5.7. System and Technology Support Services
    • 5.7.1. Global Clinical Trial Imaging Market, by System and Technology Support Services, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Clinical Trial Imaging Market, by Modality

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • 6.3. Ultrasound
    • 6.3.1. Global Clinical Trial Imaging Market, by Ultrasound, by Region, 2019-2032 (USD Million)
  • 6.4. Computed Tomography
    • 6.4.1. Global Clinical Trial Imaging Market, by Computed Tomography, by Region, 2019-2032 (USD Million)
  • 6.5. X-Ray
    • 6.5.1. Global Clinical Trial Imaging Market, by X-Ray, by Region, 2019-2032 (USD Million)
  • 6.6. Magnetic Resonance Imaging
    • 6.6.1. Global Clinical Trial Imaging Market, by Magnetic Resonance Imaging, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Clinical Trial Imaging Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 7.3. Neurology
    • 7.3.1. Global Clinical Trial Imaging Market, by Neurology, by Region, 2019-2032 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Global Clinical Trial Imaging Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Global Clinical Trial Imaging Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 7.6. Endocrinology
    • 7.6.1. Global Clinical Trial Imaging Market, by Endocrinology, by Region, 2019-2032 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Global Clinical Trial Imaging Market, by Ophthalmology, by Region, 2019-2032 (USD Million)
  • 7.8. Cardiovascular Diseases
    • 7.8.1. Global Clinical Trial Imaging Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Million)
  • 7.9. Others
    • 7.9.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Clinical Trial Imaging Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Clinical Trial Imaging Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Contract Research Organizations
    • 8.4.1. Global Clinical Trial Imaging Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.5. Medical Device Manufacturers
    • 8.5.1. Global Clinical Trial Imaging Market, by Medical Device Manufacturers, by Region, 2019-2032 (USD Million)
  • 8.6. Academic and Government Research Institutes
    • 8.6.1. Global Clinical Trial Imaging Market, by Academic and Government Research Institutes, by Region, 2019-2032 (USD Million)
  • 8.7. Others
    • 8.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Clinical Trial Imaging Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Clinical Trial Imaging Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Clinical Trial Imaging Market - North America
    • 9.3.1. North America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.3.2. North America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.3.4. North America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.3.5. Clinical Trial Imaging Market - U.S.
      • 9.3.5.1. U.S.: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.3.6. Clinical Trial Imaging Market - Canada
      • 9.3.6.1. Canada: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.4. Clinical Trial Imaging Market - Europe
    • 9.4.1. Europe: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.4.2. Europe: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.4.4. Europe: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.5. Clinical Trial Imaging Market - UK
      • 9.4.5.1. UK: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.6. Clinical Trial Imaging Market - France
      • 9.4.6.1. France: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.6.2. France: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.6.4. France: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.7. Clinical Trial Imaging Market - Germany
      • 9.4.7.1. Germany: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.8. Clinical Trial Imaging Market - Italy
      • 9.4.8.1. Italy: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.9. Clinical Trial Imaging Market - Spain
      • 9.4.9.1. Spain: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.10. Clinical Trial Imaging Market - Netherlands
      • 9.4.10.1. Netherlands: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.11. Clinical Trial Imaging Market - Russia
      • 9.4.11.1. Russia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.5. Clinical Trial Imaging Market - Asia Pacific
    • 9.5.1. Asia Pacific: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.5. Clinical Trial Imaging Market - China
      • 9.5.5.1. China: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.5.4. China: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.6. Clinical Trial Imaging Market - India
      • 9.5.6.1. India: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.6.4. India: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.7. Clinical Trial Imaging Market - Japan
      • 9.5.7.1. Japan: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.8. Clinical Trial Imaging Market - Malaysia
      • 9.5.8.1. Malaysia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.9. Clinical Trial Imaging Market - Indonesia
      • 9.5.9.1. Indonesia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.10. Clinical Trial Imaging Market - South Korea
      • 9.5.10.1. South Korea: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.6. Clinical Trial Imaging Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.5. Clinical Trial Imaging Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.6. Clinical Trial Imaging Market - South Africa
      • 9.6.6.1. South Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.7. Clinical Trial Imaging Market - Israel
      • 9.6.7.1. Israel: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.8. Clinical Trial Imaging Market - UAE
      • 9.6.8.1. UAE: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.7. Clinical Trial Imaging Market - Latin America
    • 9.7.1. Latin America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.5. Clinical Trial Imaging Market - Mexico
      • 9.7.5.1. Mexico: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.6. Clinical Trial Imaging Market - Brazil
      • 9.7.6.1. Brazil: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.7. Clinical Trial Imaging Market - Argentina
      • 9.7.7.1. Argentina: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. BioClinica
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Biomedical Systems Corp
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BioTelemetry, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Cardiovascular Imaging Technologies
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. ICON plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Intrinsic Imaging
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. IXICO plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Median Technologies
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Medpace
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merge Healthcare
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Navitas Clinical Research, Inc
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. ProScan Imaging
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Radiant Sage LLC
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Resonance Health
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. WorldCare Clinical
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Clinical Trial Imaging Market, by Offering, by Region, 2019-2032 (USD Million)
  • Table 2 Global Clinical Trial Imaging Market, by Modality, by Region, 2019-2032 (USD Million)
  • Table 3 Global Clinical Trial Imaging Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 4 Global Clinical Trial Imaging Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Clinical Trial Imaging Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 7 North America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 8 North America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 9 North America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 10 U.S.: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 11 U.S.: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 12 U.S.: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 13 U.S.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 14 Canada: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 15 Canada: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 16 Canada: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 17 Canada: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 18 Europe: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 19 Europe: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 20 Europe: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 22 Germany: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 23 Germany: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 24 Germany: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 26 France: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 27 France: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 28 France: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 29 France: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 30 UK: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 31 UK: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 32 UK: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 33 UK: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 34 Italy: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 35 Italy: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 36 Italy: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 37 Italy: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 38 Netherlands: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 39 Netherlands: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 40 Netherlands: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 41 Netherlands: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 42 Spain: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 43 Spain: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 44 Spain: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 45 Spain: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 46 Russia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 47 Russia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 48 Russia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 49 Russia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 54 China: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 55 China: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 56 China: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 57 China: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 58 Japan: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 59 Japan: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 60 Japan: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 61 Japan: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 62 India: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 63 India: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 64 India: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 65 India: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 66 Indonesia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 67 Indonesia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 68 Indonesia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 69 Indonesia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 70 Malaysia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 71 Malaysia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 72 Malaysia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 73 Malaysia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 74 South Korea: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 75 South Korea: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 76 South Korea: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 77 South Korea: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 78 Latin America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 79 Latin America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 80 Latin America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 81 Latin America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 82 Brazil: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 83 Brazil: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 84 Brazil: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 85 Brazil: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 86 Mexico: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 87 Mexico: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 88 Mexico: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 89 Mexico: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 90 Argentina: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 91 Argentina: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 92 Argentina: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 93 Argentina: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 98 UAE: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 99 UAE: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 100 UAE: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 101 UAE: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 106 South Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 107 South Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 108 South Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 109 South Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 110 Israel: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 111 Israel: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 112 Israel: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 113 Israel: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Clinical Trial Imaging Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global Clinical Trial Imaging Market, by Offering, 2021 & 2030 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Clinical Trial Imaging Market, by End User, 2021 & 2030 (USD Million)
  • Figure 10. Market by Modality
  • Figure 11. Global Clinical Trial Imaging Market, by Modality, 2021 & 2030 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global Clinical Trial Imaging Market, by Application, 2021 & 2030 (USD Million)